- Home
- OM vs NVNO Comparison
OM vs NVNO Comparison
Compare OM & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- NVNO
- Stock Information
- Founded
- OM 2003
- NVNO 1987
- Country
- OM United States
- NVNO United States
- Employees
- OM N/A
- NVNO N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NVNO Medical/Dental Instruments
- Sector
- OM Health Care
- NVNO Health Care
- Exchange
- OM Nasdaq
- NVNO Nasdaq
- Market Cap
- OM 50.5M
- NVNO 41.0M
- IPO Year
- OM 2020
- NVNO N/A
- Fundamental
- Price
- OM $15.30
- NVNO $3.65
- Analyst Decision
- OM Buy
- NVNO
- Analyst Count
- OM 2
- NVNO 0
- Target Price
- OM $29.50
- NVNO N/A
- AVG Volume (30 Days)
- OM 157.4K
- NVNO 77.0K
- Earning Date
- OM 05-07-2025
- NVNO 05-01-2025
- Dividend Yield
- OM N/A
- NVNO N/A
- EPS Growth
- OM N/A
- NVNO N/A
- EPS
- OM N/A
- NVNO N/A
- Revenue
- OM $115,273,000.00
- NVNO N/A
- Revenue This Year
- OM $8.98
- NVNO N/A
- Revenue Next Year
- OM $12.74
- NVNO $409.09
- P/E Ratio
- OM N/A
- NVNO N/A
- Revenue Growth
- OM N/A
- NVNO N/A
- 52 Week Low
- OM $5.85
- NVNO $2.03
- 52 Week High
- OM $78.30
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- OM 67.56
- NVNO 71.64
- Support Level
- OM $11.19
- NVNO $2.61
- Resistance Level
- OM $12.79
- NVNO $3.97
- Average True Range (ATR)
- OM 1.22
- NVNO 0.22
- MACD
- OM 0.44
- NVNO 0.11
- Stochastic Oscillator
- OM 79.36
- NVNO 80.00
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.